Menopause & Hormones: What the “Black Box Warning” Didn’t Tell You

Nov 12, 2025
4 min read

Updated: Jul 15

For decades, menopause has been something women were expected to simply “get through.”

Hot flashes, mood swings, joint pain - often dismissed as just part of aging.

But what about the things no one explained?

Today, the conversation is beginning to shift. Science is catching up, and women’s health after 40 is finally receiving more focused attention. Women were handed fear, silence, and oversimplified advice around menopause for decades. Now the conversation is becoming more nuanced, and women deserve care that helps them understand their options clearly.

In November 2025, the U.S. Food and Drug Administration announced it was initiating changes to remove broad boxed warnings from many menopausal hormone therapy products. The change does not mean hormone therapy is risk-free, but it does reflect a more nuanced conversation about age, timing, route of delivery, symptoms, and individual risk.

If you’ve been wondering what that means - and what it means for you - let’s break it down.

What the Box Warning Said

When the Women’s Health Initiative (WHI) study was released in 2002, the FDA required all estrogen and estrogen-progestin therapies to carry a “black box warning” the strongest caution a medication label can have.

The warning stated that estrogen therapy (ET) and combined estrogen-progestin therapy (EPT) were associated with increased risks of:

Breast cancer
Heart disease
Stroke
Blood clots

It also advised that hormone therapy should be used at the lowest effective dose for the shortest duration possible to manage menopausal symptoms.

Women were told hormone therapy was dangerous, menopause was something to endure, and symptoms were just part of aging. Now the conversation is becoming more nuanced, but many women are still left trying to understand what is safe, what is supportive, and what questions to ask.

Why This Matters More Than You’ve Been Told

Hormones have been part of women’s lives from puberty to pregnancy, contraception, and eventually menopause. We’ve been put on cycles of hormone therapy to manage life transitions, sometimes without truly understanding the impact on our whole body.

Menopause isn’t just the end of a reproductive chapter, it’s another whole-body transition.

Research is uncovering just how connected estrogen is to our joints, brain, skin, and sleep. It’s no wonder so many women describe feeling like strangers in their own bodies during this time.

What’s Changing Now

The FDA has announced that the black box warning will be removed or revised for many hormone therapy products. This doesn’t mean HRT is risk-free, but it does mean the conversation is finally evolving to reflect current science.

Here’s what we now know:

Risks vary depending on age, timing, and type of therapy.
Timing matters: Women who start HRT within 10 years of menopause or before age 60 often have more benefits than risks.
Different therapies, different effects: Oral, transdermal, and vaginal hormones affect the body in unique ways.
Beyond hot flashes: Estrogen supports bone density, cardiovascular health, mood, and even cartilage integrity.

Why the change? The original Women’s Health Initiative (WHI) study mostly looked at women who started HRT long after menopause, often in their 60s or 70s. Newer research shows that starting closer to menopause can actually provide a favourable risk-benefit profile, supporting heart, bone, and cognitive health for many women.

This growing evidence led the FDA to revisit the black box warning, recognizing that the previous label painted an overly broad and often misleading picture of risk.

Where lifestyle and hormone therapy can both fit

Lifestyle, nutrition, movement, sleep, stress support, and targeted supplements can all play meaningful roles in midlife health. For some women, menopausal hormone therapy may also be part of a thoughtful care plan. The question is not whether natural support or medical care is “better.” The question is what is appropriate, safe, and supportive for the individual woman in front of us.

For some women, supporting menopause naturally may include nutrition, movement, stress support, sleep, and targeted supplements. For others, hormone therapy may be part of the picture. For many, the most supportive path may include both.

For some women, lifestyle changes, nutrition, and stress support may bring balance naturally.
For others, HRT might be the missing piece to restore vitality and comfort.

It doesn’t have to be one or the other it can be both, intentionally combined to support your best health.

What does the boxed warning change mean for Canadians?

In Canada, the equivalent regulatory body to the FDA is Health Canada. They make decisions based on Canadian studies, standards, and priorities not automatically based on FDA decisions.

When the FDA removes or changes a warning like a black box, it may influence Health Canada’s review, but there’s no guarantee of immediate change.

Canadians should still check Canadian-approved guidelines and consult with their healthcare providers, because regulatory standards and available medications may differ.

The Bottom Line

The removal of the black box is a win for curiosity, clarity, and confident choices for the ability to ask questions, weigh risks, and make decisions rooted in your unique body and health story.

Menopause deserves more than silence or fear. it deserves curiosity, compassion, and care that sees the whole woman.